TAYLOR MORRIS EYEWEAR Unisex Sonnenbrille UV400 SW9 50C3 Xerolacer Der Farbton 3C2 Pebble ist BTS_3700928802478

Name: TAYLOR MORRIS EYEWEAR Unisex Sonnenbrille UV400 SW9 50C3 Xerolacer Der Farbton 3C2 Pebble ist BTS_3700928802478
Brand: growinghearts.net
SKU: 22040113873
Price: 72.00 USD
Availability: InStock
Rating: 4.6858 (29 reviews)

SKU 22040113873 · ★ 4.7

EUR72.00 EUR108.00

Pay in 4 interest-free payments of $18.00 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Oct 21 - Oct 26

Forum notes

Description

TAYLOR MORRIS EYEWEAR Unisex Sonnenbrille UV400 SW9 50C3 Xerolacer Der Farbton 3C2 Pebble ist BTS_3700928802478 Der Farbton 3C2 Pebble ist auf einen natürlichen Teint ausgerichtet traditionellen Anzeige bevorzugen Die TAYLOR MORRIS EYEWEAR Unisex Sonnenbrille UV400 SW9 50C3 verbindet ein markantes Erscheinungsbild mit einem praktischen UV Schutz für sonnige Tage Der UV400 Schutz unterstützt den Schutz der Augen vor ultravioletter Strahlung gemäss den Herstellerangaben

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

Frequently Asked Questions for TAYLOR MORRIS EYEWEAR Unisex Sonnenbrille UV400 SW9 50C3 Xerolacer Der Farbton 3C2 Pebble ist BTS_3700928802478

How can I find out whether a special request can be accommodated?

Confirm any new requirements that would apply to the modified offer. Keep unconfirmed wishes separate from details the seller has actually agreed to provide.

How can I decide whether this product meets my needs?

Compare the stated product information with the features you actually need. If an important detail cannot be confirmed, keep that uncertainty in your comparison.

What should I do if a product listing disappears after I order?

Ask about any proposed change before agreeing to a substitute. Verify the actual order outcome independently of public listing availability.